First Pacific Financial’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.91K Sell
47
-37
-44% -$6.96K ﹤0.01% 424
2026
Q1
$16.6K Buy
84
+36
+75% +$6.94K ﹤0.01% 324
2025
Q4
$8.79K Sell
48
-2
-4% -$351 ﹤0.01% 341
2025
Q3
$7.57K Buy
50
+2
+4% +$303 ﹤0.01% 344
2025
Q2
$6.64K Hold
48
﹤0.01% 361
2025
Q1
$6.98K Buy
+48
New +$6.95K ﹤0.01% 331

Other funds holding AZN

First Pacific Financial's AZN Position: Q2 2026 in Review

First Pacific Financial reduced its AstraZeneca (AZN) stake by 44% in Q2 2026, selling an estimated $6.96K and leaving 47 shares worth $8.91K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

First Pacific Financial first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.6K in Q1 2026. 537 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • First Pacific Financial held 47 shares of AstraZeneca worth $8.91K as of Q2 2026.
  • First Pacific Financial sold 37 AstraZeneca shares in Q2 2026, an estimated $6.96K.
  • AstraZeneca made up ﹤0.01% of First Pacific Financial's portfolio in Q2 2026, its #424 holding.
  • First Pacific Financial first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
  • First Pacific Financial's AstraZeneca position peaked at $16.6K in Q1 2026.
  • 537 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.